Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

Jaffer A. Ajani; Thomas A. D'Amico; Khaldoun Almhanna; David J. Bentrem; Joseph Chao; Prajnan Das; Crystal S. Denlinger; Paul Fanta; Farhood Farjah; Charles S. Fuchs; Hans Gerdes; Michael Gibson; Robert E. Glasgow; James A. Hayman; Steven Hochwald; Wayne L. Hofstetter; David H. Ilson; Dawn Jaroszewski; Kimberly L. Johung; Rajesh N. Keswani; Lawrence R. Kleinberg; W. Michael Korn; Stephen Leong; Catherine Linn; A. Craig Lockhart; Quan P. Ly; Mary F. Mulcahy; Mark B. Orringer; Kyle A. Perry; George A. Poultsides; Walter J. Scott; Vivian E. Strong; Mary Kay Washington; Benny Weksler; Christopher G. Willett; Cameron D. Wright; Debra Zelman; Nicole McMillian; Hema Sundar

doi:10.6004/jnccn.2016.0137

Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D'Amico, Khaldoun Almhanna, David J. Bentrem, Joseph Chao, Prajnan Das, Crystal S. Denlinger, Paul Fanta, Farhood Farjah, Charles S. Fuchs, Hans Gerdes, Michael Gibson, Robert E. Glasgow, James A. Hayman, Steven Hochwald, Wayne L. Hofstetter, David H. Ilson, Dawn Jaroszewski, Kimberly L. Johung, Rajesh N. KeswaniLawrence R. Kleinberg, W. Michael Korn, Stephen Leong, Catherine Linn, A. Craig Lockhart, Quan P. Ly, Mary F. Mulcahy, Mark B. Orringer, Kyle A. Perry, George A. Poultsides, Walter J. Scott, Vivian E. Strong, Mary Kay Washington, Benny Weksler, Christopher G. Willett, Cameron D. Wright, Debra Zelman, Nicole McMillian, Hema Sundar

Research output: Contribution to journal › Review article › peer-review

751 Scopus citations

Abstract

Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of death from cancer in the world. Several advances have been made in the staging procedures, imaging techniques, and treatment approaches. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer provide an evidence- and consensus-based treatment approach for the management of patients with gastric cancer. This manuscript discusses the recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease.

Original language	English (US)
Pages (from-to)	1286-1312
Number of pages	27
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	14
Issue number	10
DOIs	https://doi.org/10.6004/jnccn.2016.0137
State	Published - Oct 1 2016

Funding

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/jnccn.2016.0137

Cite this

Ajani, J. A., D'Amico, T. A., Almhanna, K., Bentrem, D. J., Chao, J., Das, P., Denlinger, C. S., Fanta, P., Farjah, F., Fuchs, C. S., Gerdes, H., Gibson, M., Glasgow, R. E., Hayman, J. A., Hochwald, S., Hofstetter, W. L., Ilson, D. H., Jaroszewski, D., Johung, K. L., ... Sundar, H. (2016). Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network, 14(10), 1286-1312. https://doi.org/10.6004/jnccn.2016.0137

@article{739ddb158da6489295cce7ffcc9c4f2b,

title = "Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology",

abstract = "Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of death from cancer in the world. Several advances have been made in the staging procedures, imaging techniques, and treatment approaches. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer provide an evidence- and consensus-based treatment approach for the management of patients with gastric cancer. This manuscript discusses the recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease.",

author = "Ajani, {Jaffer A.} and D'Amico, {Thomas A.} and Khaldoun Almhanna and Bentrem, {David J.} and Joseph Chao and Prajnan Das and Denlinger, {Crystal S.} and Paul Fanta and Farhood Farjah and Fuchs, {Charles S.} and Hans Gerdes and Michael Gibson and Glasgow, {Robert E.} and Hayman, {James A.} and Steven Hochwald and Hofstetter, {Wayne L.} and Ilson, {David H.} and Dawn Jaroszewski and Johung, {Kimberly L.} and Keswani, {Rajesh N.} and Kleinberg, {Lawrence R.} and Korn, {W. Michael} and Stephen Leong and Catherine Linn and Lockhart, {A. Craig} and Ly, {Quan P.} and Mulcahy, {Mary F.} and Orringer, {Mark B.} and Perry, {Kyle A.} and Poultsides, {George A.} and Scott, {Walter J.} and Strong, {Vivian E.} and Washington, {Mary Kay} and Benny Weksler and Willett, {Christopher G.} and Wright, {Cameron D.} and Debra Zelman and Nicole McMillian and Hema Sundar",

year = "2016",

month = oct,

day = "1",

doi = "10.6004/jnccn.2016.0137",

language = "English (US)",

volume = "14",

pages = "1286--1312",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "10",

}

Ajani, JA, D'Amico, TA, Almhanna, K, Bentrem, DJ, Chao, J, Das, P, Denlinger, CS, Fanta, P, Farjah, F, Fuchs, CS, Gerdes, H, Gibson, M, Glasgow, RE, Hayman, JA, Hochwald, S, Hofstetter, WL, Ilson, DH, Jaroszewski, D, Johung, KL, Keswani, RN, Kleinberg, LR, Korn, WM, Leong, S, Linn, C, Lockhart, AC, Ly, QP, Mulcahy, MF, Orringer, MB, Perry, KA, Poultsides, GA, Scott, WJ, Strong, VE, Washington, MK, Weksler, B, Willett, CG, Wright, CD, Zelman, D, McMillian, N & Sundar, H 2016, 'Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 10, pp. 1286-1312. https://doi.org/10.6004/jnccn.2016.0137

TY - JOUR

T1 - Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

AU - Ajani, Jaffer A.

AU - D'Amico, Thomas A.

AU - Almhanna, Khaldoun

AU - Bentrem, David J.

AU - Chao, Joseph

AU - Das, Prajnan

AU - Denlinger, Crystal S.

AU - Fanta, Paul

AU - Farjah, Farhood

AU - Fuchs, Charles S.

AU - Gerdes, Hans

AU - Gibson, Michael

AU - Glasgow, Robert E.

AU - Hayman, James A.

AU - Hochwald, Steven

AU - Hofstetter, Wayne L.

AU - Ilson, David H.

AU - Jaroszewski, Dawn

AU - Johung, Kimberly L.

AU - Keswani, Rajesh N.

AU - Kleinberg, Lawrence R.

AU - Korn, W. Michael

AU - Leong, Stephen

AU - Linn, Catherine

AU - Lockhart, A. Craig

AU - Ly, Quan P.

AU - Mulcahy, Mary F.

AU - Orringer, Mark B.

AU - Perry, Kyle A.

AU - Poultsides, George A.

AU - Scott, Walter J.

AU - Strong, Vivian E.

AU - Washington, Mary Kay

AU - Weksler, Benny

AU - Willett, Christopher G.

AU - Wright, Cameron D.

AU - Zelman, Debra

AU - McMillian, Nicole

AU - Sundar, Hema

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of death from cancer in the world. Several advances have been made in the staging procedures, imaging techniques, and treatment approaches. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer provide an evidence- and consensus-based treatment approach for the management of patients with gastric cancer. This manuscript discusses the recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease.

AB - Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of death from cancer in the world. Several advances have been made in the staging procedures, imaging techniques, and treatment approaches. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer provide an evidence- and consensus-based treatment approach for the management of patients with gastric cancer. This manuscript discusses the recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease.

UR - http://www.scopus.com/inward/record.url?scp=84990196174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990196174&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2016.0137

DO - 10.6004/jnccn.2016.0137

M3 - Review article

C2 - 27697982

AN - SCOPUS:84990196174

SN - 1540-1405

VL - 14

SP - 1286

EP - 1312

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 10

ER -

Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

Abstract

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this